XBiotech XBIT
NASDAQ XBIT
$1.91 +0.04 (+2.14%)
At close: Nov 9, 2026 · 4:00 PM EST

XBiotech (XBIT) Short term Debt (2024)

Updated

Analysis

XBiotech (XBIT) Short term Debt (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,261.99 Bn 1,235.61 Bn 20.46 Bn
2 Johnson & Johnson 678.93 Bn 598.79 Bn 17.30 Bn
3 AbbVie 518.29 Bn 486.30 Bn 13.12 Bn
4 Merck 365.98 Bn 328.92 Bn 13.19 Bn
5 Novartis Ag 316.85 Bn 290.09 Bn -
6 Astrazeneca 293.40 Bn 267.29 Bn 13.26 Bn
7 Amgen 251.78 Bn 203.43 Bn 7.58 Bn
8 Gilead Sciences 210.61 Bn 185.71 Bn 6.73 Bn
9 Pfizer 166.87 Bn 114.23 Bn 12.56 Bn
10 XBiotech 58.23 Mn -439.75 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 10.25 Mn
Sep 30, 2024 10.00 Mn
Jun 30, 2024 10.00 Mn
Mar 31, 2024 10.00 Mn
API Access

XBiotech Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=XBIT&period=max&api_key=YOUR_API_KEY